Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation.

@article{Nazmul2013PercutaneousPO,
  title={Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation.},
  author={Mohammed N Nazmul and Yongmei Cha and Grace Shou-Yean Lin and Samuel J. Asirvatham and Brian D. Powell},
  journal={Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology},
  year={2013},
  volume={15 3},
  pages={
          409-13
        }
}
AIMS Pacemaker and implantable cardioverter-defibrillator (ICD) leads can cause tricuspid valve regurgitation (TR). Few data are available on the best management of significant TR that develops after pacemaker or ICD implantation and regarding any benefits of right ventricular (RV) lead extraction. We sought to determine the impact of RV lead removal on lead-induced TR. METHODS AND RESULTS We reviewed all patients between 1 January 2000 and 31 December 2010 at the tertiary care hospital who… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

Diagnosis of lead-induced tricuspid regurgitation

VIEW 12 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED